National Institute of Allergy and Infectious Diseases

From WikiMD's WELLNESSPEDIA

(Redirected from NIAID)

National Institute of Allergy and Infectious Diseases (NIAID) is a part of the United States Department of Health and Human Services and is tasked with conducting and supporting basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases.

History[edit]

The NIAID was established in 1955 as a response to the need for research on allergy, infectious diseases, and immunology. Over the years, it has been at the forefront of research on various diseases such as HIV/AIDS, influenza, malaria, Ebola, and most recently, COVID-19. The institute has played a crucial role in developing vaccines, treatments, and diagnostics for numerous diseases.

Mission and Activities[edit]

The primary mission of NIAID is to lead research to understand, treat, and prevent infectious, immunologic, and allergic diseases. This involves a wide range of activities including basic and clinical research, funding external research, and collaborating with other research organizations and pharmaceutical companies. NIAID also plays a key role in responding to public health emergencies.

Research Areas[edit]

NIAID focuses on a broad spectrum of research areas including:

These research areas encompass a wide range of diseases and conditions, from common allergies to life-threatening infections.

Facilities[edit]

NIAID operates several state-of-the-art research facilities, including laboratories at the National Institutes of Health (NIH) campus in Bethesda, Maryland, and at various locations across the United States and around the world. These facilities are equipped with advanced technologies that enable scientists to conduct high-level research.

Funding and Grants[edit]

NIAID supports a vast network of researchers through grants and contracts. The institute provides funding for research projects, training programs, and collaborative research initiatives. Funding opportunities are available for both domestic and international researchers.

Public Health Impact[edit]

The work of NIAID has had a significant impact on public health. The institute's research has led to the development of numerous vaccines, antiviral drugs, diagnostic tests, and treatment protocols. These advancements have saved millions of lives and improved the quality of life for people with chronic infectious and immune-mediated diseases.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.